Zhang Zhi Xian; Gu Hou; Lin 劼; Lei Xue Fen; Jiang Li Feng; Li Nan; Lu Xin Yan

Volume 40 Issue 02

Turn off MathJax

Article Contents

References

Relative Articles

Article Navigation > Journal of Kunming Medical University > 2019 > 40(02): 123-127

PDF( 1543 KB)

Abstract

FullText(HTML)

References(0)

References

Relative Articles(20)

Relative Articles

[1]	Shengxi YANG, Jiade ZHU, Qiurui LI, Wenlian TU. Clinical Study of Aumolertinib Versus Osimertinib in the Treatment of EGFR-Mutated Advanced Non-Small Cell Lung Cancer. Journal of Kunming Medical University, 2025, 46(5): 1-7.
[2]	Ling MA, Yanhong ZHAO, Jia LIU, Wenlian TU. Cost-Effectiveness Analysis of Nilotinib Versus Dasatinib as Second-Line Treatment of Chronic Myeloid Leukemia. Journal of Kunming Medical University, 2024, 45(4): 92-98. doi: 10.12259/j.issn.2095-610X.S20240413
[3]	Dongyan YANG, Hua LIN, Yuxiao ZHANG, Kunying ZHAO, Lirong XIANG, Shuda YANG, Weiyan HU. Efficacy and Safety of Bevacizumab Combined with Temozolomide for Recurrent High-Grade Glioma. Journal of Kunming Medical University, 2024, 45(4): 67-73. doi: 10.12259/j.issn.2095-610X.S20240410
[4]	Haoyuan LI, Ming HUANG, Jingmei ZHOU, Jianjie HUA, Qijie WU, Rong DING. Comparison of Early Recurrence after Microwave Ablation for Liver Metastases of Colorectal Cancer Guided by Different Imaging Techniques Based on Propensity Score Matching. Journal of Kunming Medical University, 2024, 46(): 1-6.
[5]	Jian-ping LI, Xue-ren GAO, Xiao-yan ZHANG, Ping CHEN, Su-rong CHEN, Wei-gang BIAN, Zhi-jun HUANG. Efficacy and Safety of Capecitabine Combined with Bevacizumab or Single Agent of Capecitabine as Maintenance Therapy for Advanced Colorectal Cancer. Journal of Kunming Medical University, 2021, 42(9): 119-126. doi: 10.12259/j.issn.2095-610X.S20210908
[6]	Zhang Zhi Xian , Gu Hou , Feng Xin Rong , Lin 劼, Lei Xue Fen , Li Nan , Li Rui Zhi , Yu Jia . . Journal of Kunming Medical University, 2020, 41(05): 70-74.
[7]	Wang Ye Jing , Liu Huai Lei . . Journal of Kunming Medical University, 2019, 40(08): 52-56.
[8]	Zhang Na , He Wen Xian , Yang Xue Mei , Li Gui Ping , Cui Yan Ting , Wu Jiang Hong . . Journal of Kunming Medical University, 2019, 40(04): 117-120.
[9]	Zhang Zhi Xian , Gu Hou , Lin 劼, Lei Xue Fen , Jiang Li Feng , Li Nan , Lu Xin Yan , Li Rui Zhi . . Journal of Kunming Medical University, 2019, 40(07): 111-115.
[10]	Zhang Zhi Xian , Gu Hou , Lin 劼, Lei Xue Fen , Jiang Li Feng , Li Nan , Lu Xin Yan , Yu Jia . . Journal of Kunming Medical University, 2019, 40(08): 97-101.
[11]	Jiang Bo , Lin Chao . The Effect of Oxaliplatin Injection Combined with S-1 on Levels of CEA, CA199, TAM and the Quality of Life of Patients with Advanced Gastric Cancer. Journal of Kunming Medical University, 2018, 39(01): 113-117.
[12]	Zhang Zhi Xian , Gu Hou , Lin 劼, Cao Hong Ming , Lei Xue Fen , Jiang Li Feng . . Journal of Kunming Medical University, 2018, 39(10): 33-37.
[13]	Zhang Zhi Xian , Gu Hou , Lin 劼, Lei Xue Fen , Jiang Li Feng , Li Nan , Lu Xin Yan , Li Ting Ting . . Journal of Kunming Medical University, 2018, 39(12): 65-68.
[14]	Xu Xiao Hong . Clinical Analysis of Preoperative Neoadjuvant Chemotherapy by Thalidomide Combined with Gefitinib for Non-small Cell Lung Cancer. Journal of Kunming Medical University,
[15]	Zhang Sheng Ning . . Journal of Kunming Medical University,
[16]	Long Xiang Yu . . Journal of Kunming Medical University,
[17]	Wang Hua . . Journal of Kunming Medical University,
[18]	Wu Xue Song . . Journal of Kunming Medical University,
[19]	Yang Jie . Comparison of S-1 Combined with Radical Radiation Therapy and Single Radical Radiation Therapy in Treatment of Early Nasopharyngeal Carcinoma. Journal of Kunming Medical University,
[20]	Yang Jie . Clinical Application of I125-seed Implantation Combined with Gimeracil and Oteracil Capsules Adjuvant Chemotherapy in the Treatment of Head and Neck Cancer. Journal of Kunming Medical University,

Supplements(0)

Cited By

Cited by

Periodical cited type(13)

1.	胡晓彤，于泉，蔡照华. 阿帕替尼联合程序性死亡受体1抑制剂治疗晚期结直肠癌患者的应用价值. 大医生. 2024(05): 65-67 .
2.	孙鸿燕，许永春，李志晋，黄勇亮，马曦. 阿帕替尼联合奥沙利铂、雷替曲塞方案对晚期结直肠癌的应用效果分析. 转化医学杂志. 2024(04): 628-631 .
3.	张强，邢迎清，王朝阳，贺许良. 雷替曲塞联合阿帕替尼对结肠癌细胞增殖的影响及其机制. 山东医药. 2022(01): 44-47 .
4.	朱娜，胡鑫，杨春燕. 阿帕替尼辅助DP方案治疗晚期非小细胞肺癌的疗效及对血清hCAP18和Pokemon表达的影响. 南昌大学学报(医学版). 2022(01): 56-60 .
5.	王德银，郭海渊博，李博. DEBIRI-TACE联合FOLFOX方案治疗对结直肠癌肝转移患者免疫功能及远期疗效的影响. 中国医师杂志. 2022(03): 432-435 .
6.	汪洪刚. 雷替曲塞联合奥沙利铂治疗结直肠癌肝转移的临床应用. 中国实用医药. 2021(03): 100-102 .
7.	施志杰. 阿帕替尼治疗晚期结直肠癌的有效性和安全性. 临床医学. 2021(05): 90-93 .
8.	贺志云，党洁，崔祥，彭正奎，马天龙，樊景春. 阿帕替尼和替吉奥对结肠癌治疗效果的系统评价和Meta分析. 国际外科学杂志. 2021(03): 175-178, F4+175-178, F4 .
9.	赵仔君，宁周雨，王玮，张为强. 雷替曲塞和铂类肝动脉灌注化疗治疗胃癌术后肝转移的疗效观察. 中国肿瘤临床与康复. 2021(08): 922-925 .
10.	艾岩，朱方勇. 阿帕替尼联合替吉奥二线治疗胃癌患者的临床效果. 临床合理用药杂志. 2021(26): 90-92 .
11.	钟俊斌，魏建昌，王强，杨平，胡石奇，李旺林，曹杰. 雷替曲塞联合奥沙利铂与FOLFOX4方案对晚期结直肠癌临床综合疗效及安全性比较研究. 中外医学研究. 2020(19): 21-23 .
12.	姜红. 雷替曲塞在晚期肠癌二线化疗中的疗效分析. 中国医药指南. 2020(27): 109-110 .
13.	胡妍，石巧，廖丽丽. 心理护理在益气健脾汤联合雷替曲塞治疗结直肠癌护理中的应用探讨. 中国医药指南. 2019(28): 269-270 .